AstraZeneca PLC
1566.00
31-January-25 11:29:40
15 minutes delayed
Stocks
+10.00
+0.64%
Today's range
1557.50 - 1572.00
ISIN
N/A
Source
NASD.OMX SE
-
Here's What AstraZeneca's CEO Has to Say About the Weight Loss Drugs Market
04 Aug 2024 10:42:17 By NASDAQ US Markets
-
NetDania - New 12 months High: AstraZeneca PLC
29 Jul 2024 08:07:19 By NetDania Notify
-
AstraZeneca: Calquence Combo Enhances PFS In First-Line CLL In Phase III Trial
29 Jul 2024 03:38:02 By NASDAQ US Markets
-
AstraZeneca Reports ODAC's Review Of Imfinzi - Quick Facts
26 Jul 2024 03:05:05 By NASDAQ US Markets
-
NetDania - New 12 months High: AstraZeneca PLC
25 Jul 2024 03:15:03 By NetDania Notify
-
AstraZeneca Q2 Profit Rises, Lifts FY24 Outlook
25 Jul 2024 02:51:34 By NASDAQ US Markets
-
NetDania - New 12 months High: AstraZeneca PLC
23 Jul 2024 06:15:26 By NetDania Notify
-
NetDania - New 12 months High: AstraZeneca PLC
22 Jul 2024 08:17:57 By NetDania Notify
-
Interesting AZN Put And Call Options For August 23rd
03 Jul 2024 13:16:51 By NASDAQ US Markets
-
AstraZeneca: CHMP Recommends Lynparza And Imfinzi Combination For EU Approval In Endometrial Cancer
01 Jul 2024 03:09:21 By NASDAQ US Markets
-
Pharma Stock Roundup: FDA's CRL to MRK & ABBV, Phase III Study Failures for NVO, AZN
28 Jun 2024 10:33:02 By NASDAQ Stocks
-
AstraZeneca: Imfinzi Trial Fails To Meet Endpoint In Early-stage Non-small Cell Lung Cancer
25 Jun 2024 03:08:02 By NASDAQ US Markets
-
AstraZeneca: Phase III Truqap Trial Plus Chemotherapy Fails To Meet Primary Goals In Breast Cancer
18 Jun 2024 03:15:21 By NASDAQ US Markets
-
AstraZeneca's Calquence Combo Cuts Progression Risk By 27% In Mantle Cell Lymphoma Trial
16 Jun 2024 12:33:03 By NASDAQ US Markets
-
FDA Approves AstraZeneca's Farxiga For Pediatric Use In Type-2 Diabetes
12 Jun 2024 21:53:19 By NASDAQ US Markets
-
NetDania - New 12 months High: AstraZeneca PLC
10 Jun 2024 03:21:31 By NetDania Notify
-
1 Biopharma Stock Setting the New Standard in Cancer Care Drugs
07 Jun 2024 12:13:02 By NASDAQ Stocks
-
Summit Therapeutics, AstraZeneca And More From The Year’s Biggest Cancer Conference
05 Jun 2024 19:29:29 By Forbes - World
-
AstraZeneca Completes Acquisition Of Fusion Pharma
05 Jun 2024 03:08:45 By NASDAQ US Markets
-
CHMP Recommends Approval Of AstraZeneca's Tagrisso Combo For EGFR-Mutated Advanced Lung Cancer
03 Jun 2024 03:15:45 By NASDAQ US Markets